Health economic evaluation of home and hospital-based care in T2D patients on insulin therapy

Abstract

Background: Type 2 Diabetes is a main concern of public health in  contemporary world with remarkable mortality, delayed complications and  health costs. Governments are obliged to improve the quality of health care and consider appropriate strategies to reduce the costs. An alternative strategy for  hospital services is care at home. Therefore, this study was aimed to evaluate  the cost-effectiveness of home-based and hospital-based diabetes care.

Methods: A quasi-experimental, pre-test and post-test design was conducted in Northwest Iran. Sixty subjects who were eligible insulin-treatment type 2  diabetes mellitus were randomly assigned into two equal groups to receive home-based or conventional hospital-based care. Data on glycosylated  hemoglobin (HbA1c), hypoglycemia episodes, time needed to achieve glycemic control level, diabetes treatment satisfaction, diabetes knowledge and costs during three months were collected.

Results: The cost of home-based care in insulin therapy diabetes was 61% less compared with the hospital-based methods. The former strategy was  cost-effective in terms of reduction in HbA1C and the time needed to achieve glycemic control. The patients in home care group were more satisfied and knowledgeable.

Conclusions: The care at home approach for type 2 diabetic patients can be introduced and supported as a cost-effective care method in the country.

Keywords: Cost-effectiveness, type 2 diabetes, insulin therapy, home care, hospital care